It is thought that the Asia-Pacific component of the review, which includes PR, digital, CRM, event media, consumer advertising and healthcare, is being led out of Australia. The review is being managed by Pfizer’s in-house procurement unit.
According to sources RFPs, looking for integrated solutions, have been sent to key global holding companies. At present, Pfizer works with a range of agencies from all of the major holding companies, globally. “Pfizer is very interested in consolidating the business into a preferred holding company structure,” said a source involved in the review.
“This may be one network or more.”
